A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
about
Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory AgentsTLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes.Immune Response Modulation of Conjugated Agonists with Changing Linker LengthKill: boosting HIV-specific immune responses.Cancer therapies in HIV cure research.Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral TherapyHIV-hepatitis B virus co-infection: epidemiology, pathogenesis, and treatment.Reactivation of HIV-1 from Latency by an Ingenol Derivative from Euphorbia Kansui.The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon.Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection.HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell Function.Natural Killer cells in HIV-1 infection and therapy.Wake me up before you go: A strategy to reduce the latent HIV reservoir.Getting the "Kill" into "Shock and Kill": Strategies to Eliminate Latent HIV.Innate Immune Activation by cGMP-AMP Nanoparticles Leads to Potent and Long-Acting Antiretroviral Response against HIV-1.TLR7 agonists display potent antiviral effects against norovirus infection via innate stimulation.The latest evidence for possible HIV-1 curative strategies.Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency ReversalExposure to Prostratin but Not Bryostatin-1 Improves Natural Killer Cell Functions Including Killing of CD4 T Cells Harboring Reactivated Human Immunodeficiency VirusHuman Endogenous Retroviruses Are Ancient Acquired Elements Still Shaping Innate Immune Responses
P2860
Q28079455-5C9900B9-3661-49F6-8F87-B7080C04056BQ37460727-9AC8673E-34CF-4C79-B447-21684E3C69A3Q37634354-C5D6559A-6A99-4FAE-AE6B-F21405DDA7FEQ38800533-2B4F568F-9E63-46AC-A803-F9772389D8CBQ38949445-B814B78A-B8B9-471C-9655-431A3FFF4717Q38971085-027421C9-FF1E-4880-ABBD-C4097BA69609Q39425755-A52FE2F1-0676-4DFD-A099-C5A229058F12Q40069803-DE517FA2-0DD0-4EB4-9E67-83C1FBCE6BB7Q40098403-38E8E3CA-C839-4B08-BE3B-16C56E81E7F6Q40280217-72DEBCE3-7118-49C7-91E6-743580058B18Q40515496-6E69392D-E851-4D00-AD17-E9C5950B6E23Q41934634-97C4EA29-E63A-4065-B113-62EEB865DB83Q45874441-F6E66091-EDC7-4ED4-9735-7079E7B98657Q47555333-3BE7E7FC-D666-4ED7-B835-BEEC56BC700CQ47586914-16D302C6-AAA2-498B-8E81-4B998EB7BCF3Q51741116-DF91206D-7105-412B-A9C9-8B53753BB770Q52430553-7CFDF907-351F-4CE4-ADBC-9F98CF849297Q57425155-E4CA0D3B-D245-4250-857F-4D92601D6C73Q57565007-622B4D06-538C-4686-AAE4-FE23875F2E69Q58754303-6FD8C89E-30FE-44B3-B124-3541598B6F5D
P2860
A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A Novel Toll-Like Receptor 9 A ...... ected Autologous CD4+ T Cells.
@en
type
label
A Novel Toll-Like Receptor 9 A ...... ected Autologous CD4+ T Cells.
@en
prefLabel
A Novel Toll-Like Receptor 9 A ...... ected Autologous CD4+ T Cells.
@en
P2860
P50
P356
P1433
P1476
A Novel Toll-Like Receptor 9 A ...... ected Autologous CD4+ T Cells.
@en
P2860
P304
P356
10.1128/JVI.00222-16
P407
P50
P577
2016-02-17T00:00:00Z